PEOPLE - Novoste Corporation (US) announces resignation:
This article was originally published in Clinica
Executive Summary
Novoste Corporation, a US developer of brachytherapy systems to reduce the incidence of arterial restenosis, has announced the resignation of David Gill the company's chief operating officer and chief financial officer. The company expects to fill the position of chief financial officer in the near future.